Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs ciprofol for post-hysteroscopy anxiety
ChiCTR2300073064Phase 4Recruiting
- Sponsor
- Mengcheng County No. 1 People's Hospital
- Start
- Jun 2023
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in anxiety disorder comparing Remimazolam + remifentanil with Ciprofol + remifentanil (2 arms). Primary endpoints: Preoperative anxiety scale (PAS-7) and Visual analog anxiety scale (VAS-A). Started Jun 2023; status: recruiting.
02
Drugs
remimazolamciprofol
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on ChiCTR2300073064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073064.